Cite

HARVARD Citation

    Roy, P. et al. (2019). Efficacy and safety of a bortezomib and reduced‐intensity cytarabine‐based protocol, TMC ALLR1, for relapsed childhood ALL in India. British journal of haematology. pp. 861-865. [Online]. 
  
Back to record